Updated on March 8, 2026 by Lori Mulligan, MPH. To give you technically accurate, evidence-based information, content published on the Everlywell blog is reviewed by credentialed professionals with expertise in medical and bioscience fields.
Everlywell works with preferred partners. If you click on links or make a purchase through this page, we may earn a commission.
Is There Any Concern About Stopping Ozempic® Suddenly?
According to Dr. Cecilia Loe Wang, an endocrinology expert at UCHealth, patients generally do not need to taper their dose before stopping Ozempic®.[6] However, discontinuing the medication may increase the likelihood of regaining lost weight or experiencing worsening blood sugar control.
Research published in Diabetes, Obesity & Metabolism found that participants regained roughly two-thirds of their previous weight loss within one year after stopping once-weekly semaglutide, even when lifestyle interventions were continued. The study also observed changes in cardiometabolic markers, including type 2 diabetes, hypertension, dyslipidemia, and cardiovascular disease risk factors.[5]
These findings highlight the chronic nature of obesity and suggest that maintaining improvements in weight and metabolic health may require ongoing treatment, long-term lifestyle strategies, or continued clinical support.
Who Should Take Ozempic®?
Ozempic® is FDA-approved to treat adults with type 2 diabetes. However, the medication has also been shown to support weight loss in individuals who are overweight or living with obesity.
For people with a BMI below 30, lifestyle approaches such as diet and exercise are often recommended first. But for individuals with obesity, lifestyle changes alone may not always be sufficient. In these cases, medications like Ozempic® may help address some of the biological pathways that contribute to weight gain and related conditions such as heart disease, kidney disease, and sleep apnea.
How Does Ozempic® Work?
Ozempic® belongs to a class of medications called GLP-1 receptor agonists. These medications increase levels of GLP-1, a hormone involved in regulating blood sugar and appetite.
Higher levels of GLP-1 can reduce appetite and help people feel fuller for longer. In addition to suppressing appetite, Ozempic® may also influence how the body processes food.
Healthcare providers sometimes prescribe Ozempic® “off-label” for people living with obesity. Off-label prescribing means a medication is used for a purpose different from the one originally approved by the FDA. This is common in medical practice when clinicians determine the treatment is medically appropriate.
In the case of Ozempic®, off-label use for weight loss is closely related to its sister medication Wegovy®, which contains the same active ingredient (semaglutide) but is approved specifically for obesity at a higher dose.
What Is the Dosing Schedule for Ozempic®?
Ozempic® is typically taken once per week according to a dosing schedule determined by your healthcare provider.
The usual dosing progression includes:
- Weeks 1–4: 0.25 mg once weekly to allow the body to adjust to the medication
- Week 5 onward: 0.5 mg once weekly
- If additional glucose control is needed: The dose may be increased to 1 mg weekly
- Maximum dose: 2 mg once weekly
Always follow your healthcare provider’s instructions regarding dosing and medication use.[2]
How Effective Is Ozempic®?
Although Ozempic® is not officially approved as a weight-loss medication, weight loss has been observed in many patients using the drug to treat type 2 diabetes.
In clinical studies evaluating A1C outcomes, adults with type 2 diabetes experienced the following average weight changes:
- Ozempic®: 8 lb (0.5 mg dose) and 10 lb (1 mg dose) vs placebo: 3 lb
- Ozempic®: 12 lb (1 mg dose) and 14 lb (2 mg dose)
These results were based on starting weights of approximately 202 lb and 219 lb.[3]
What Are the Side Effects of Ozempic®?
Common side effects associated with Ozempic® are gastrointestinal and may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
These symptoms can sometimes be reduced by gradually increasing the medication dose, staying well hydrated, avoiding high-fat foods, and spacing meals appropriately.
More serious risks have also been discussed in the medical literature, including pancreatitis and a rare thyroid cancer known as medullary thyroid carcinoma. For this reason, Ozempic® is typically not prescribed to individuals with a personal history of pancreatitis or a personal or family history of medullary thyroid carcinoma.[4]
Getting Guidance Before Stopping Ozempic®
If you’re considering stopping Ozempic®, it’s important to speak with a healthcare provider first. While tapering is not typically required, a clinician can help you understand what to expect after discontinuing the medication and discuss strategies to help maintain blood sugar control or weight management.
Because obesity and type 2 diabetes are chronic conditions, many people benefit from ongoing medical guidance, lifestyle support, and monitoring over time. A healthcare provider can help you evaluate your current health status, review alternative treatment options if needed, and create a plan that supports long-term metabolic health.
Some individuals choose to explore telehealth weight management programs that connect patients with licensed providers who can evaluate eligibility for medications like semaglutide and provide ongoing guidance throughout treatment.
Related Content
How to Get Ozempic® for Weight Loss: What You Need to Know
How Quickly Does Ozempic® Work?
Ozempic® and Metformin: The Differences Explained
References
- Is Ozempic the Answer for Your Weight Loss? Cleveland Clinic. https://health.clevelandclinic.org/ozempic-for-weight-loss/amp/. March 30, 2023. Accessed on July 17, 2023.
- How to take Ozempic®. https://www.ozempic.com/how-to-take/ozempic-dosing.html. Accessed on July 17, 2023.
- Why Ozempic®? https://www.ozempic.com/why-ozempic/what-is-ozempic.html#weight. Accessed on July 17, 2023.
- Let’s stop using the term Ozempic-face. Mayo Clinic. https://mcpress.mayoclinic.org/women-health/lets-stop-using-the-term-ozempic-face/. Accessed on July 17, 2023.
- Wilding JPH. Batterham RL, Davies M, et. al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Published online 2022 May 19. doi: 10.1111/dom.14725
- UCHealth. Wegovy vs. Ozempic: The truth about new “weight-loss” drugs. UCHealth Today. Published April 5, 2023. Available at: https://www.uchealth.org/today/wegovy-vs-ozempic-the-truth-about-new-weight-loss-drugs/
Spotlight on
Featured content
Explore Everlywell
